InsidersTradesSigma
Follow the KOLINPHARMA stock price and the full management transaction log of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, KOLINPHARMA has published 1 public disclosures. The latest transaction was reported on 16 August 2023 (Sale). All data is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
1 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 August 2023
Declarations1 total
977,571 shares@ €2.667100.0% of flowShareOTCISIN IT0005322950CONSOB:136045
1 of 1 declaration
About KOLINPHARMA
KOLINPHARMA is a company specialized in the health and pharmaceutical sector, offering a range of pharmaceutical products. It is listed on the XMIL market.